問卷

TPIDB > Principal Investigator

Principal Investigator


Hualien Tzu Chi Hospital (在職)

Division of Nephrology

更新時間:2023-09-19

林于立
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2023-12-28 - 2027-02-28

Phase III

A Phase III, Randomized, Investigator-Blinded, Active-Controlled Study of Efficacy and Safety of Efepoetin Alfa for Treatment of Anemia in Patients with Chronic Kidney Disease on Dialysis
  • Condition/Disease

    Chronic Kidney Disease on Dialysis

  • Test Drug

    Efepoetin alfa (GX-E4)

Participate Sites
5Sites

Recruiting5Sites

2020-11-19 - 2024-12-31

Phase III

A Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects With Metabolic Acidosis
  • Condition/Disease

    Chronic Kidney Disease With Metabolic Acidosis

  • Test Drug

    TRC101

Participate Sites
12Sites

Recruiting11Sites

Terminated1Sites